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RpS3 is a component of the 40S ribosomal subunit of eukaryotes and also plays a role as a base damage endonuclease. Nm23-H1 encodes
nucleoside diphosphate kinase A and acts as a suppressor of metastasis in certain human tumors. RpS3 interacted with nm23-H1, and the two
proteins were colocalized in the cell periphery and cytoplasm. The 190th leucine of rpS3, and the 118th histidine and the 120th serine of nm23-H1
play key roles in the interaction of two proteins, respectively. The expression of rpS3 reduced the secretion of MMP-9 and the invasive potential in
HT1080 cells. Additionally, the phosphorylated ERK was reduced by the expression of rpS3. In MCF7 cells, where the ERK pathway is
inactivated and MMPs are not secreted and the ERK pathway can be activated by PMA, the PMA-induced ERK phosphorylation was reduced by
the expression of rpS3. However, the L190A mutant of rpS3, which did not interact with nm23-H1, did not inhibit the invasive potential, the
secretion of MMP-9, and the activation of the ERK pathway in HT1080 cells and PMA-activated MCF7 cells. These results suggest that rpS3
inhibits invasion via blocking the ERK pathway and MMP-9 secretion; the results also suggest that the interaction of rpS3 and nm23-H1 appears
to be critical in this inhibition.
© 2006 Elsevier B.V. All rights reserved.Keywords: rpS3; nm23-H1; Invasion; Metastasis suppressor1. Introduction
Ribosomal protein small subunit 3 (rpS3), one of the com-
ponents of the 40S ribosomal small subunit of the eukaryotic
ribosome, is cross-linked to eIF-2 and eIF-3, and is directly
involved in translation [1]. Additionally, rpS3 has endonuclease
activity that is involved in the repair of UV-damaged DNA. UV-
irradiated DNA has cyclobutane pyrimidine dimers (CPDs) and
apurinic/apyrimidinic (AP) sites and activates rpS3 to serve as a
DNA repair endonuclease, which cleaves a phosphodiester bond
within the CPD and AP sites [2]. It was recently reported that rpS3
is a base-damage endonuclease that cleaves various altered bases
[3]. Xeroderma pigmentosum (XP) is clinically characterized by
hypersensitivity to UV irradiation and a high propensity toward
skin cancer. It has been reported that the purification profile of rpS3
was altered in XP-D cells [2]. The overexpression of rpS3 in⁎ Corresponding author. Tel.: +82 2 3290 3442; fax: +82 2 927 9028.
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suggest that the modification and differential expression of rpS3
may be related to tumorigenesis.
Nucleoside diphosphate kinases (NDPKs) are encoded in nm23
and compose a family of highly-conserved proteins in eukaryotes
[5]. Eight different nm23 genes (nm23-H1 to nm23-H8) have been
identified in humans [5]. Nm23-H1 and H2 catalyze the phos-
phorylation of nucleoside 5′-diphosphates to triphosphates through
a ping-pong mechanism involving a high energy phosphorylated
enzyme intermediate, thus equilibrating the cellular pool of NDP
and NTP [6]. It has been reported that the histidine residue in the
active site of nm23-H1 andH2 is autophosphorylated by incubation
with NTPs, thus forming a phospho-enzyme intermediate; it has
also been reported that this intermediate phosphorylates other
proteins [7,8]. Additionally, nm23-H1 and H2 have been reported
to be associated with GTP-binding proteins [9–12]. In particular,
nm23-H2 was reported to stimulate c-myc transcription in vitro by
binding toDNA [13]. Itwas shown that nm23-H1does not function
as a c-myc transcription factor [14], but it does have transactivation
potential in its C-terminal region [15]. Nm23-H1 was reported as a
granzyme A-activated DNase during CTL-mediated apoptosis
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in gastric carcinoma, ovarian cancer, melanoma, breast cancer, and
some other cancers [6,17,18]. It was reported that the transfection of
nm23-H1 cDNA into various cancer cell lines, such as prostate
carcinoma [19,20], melanoma [21], breast carcinoma [22], and
hepatocarcinoma [23], resulted in the suppression of metastatic
potential, including motility, invasion, and colonization. The serine
44 to alanine (S44A) mutation and the histidine 118 to pheny-
lalanine (H118F) mutation were reported to abrogate the phos-
phorylation of nm23- H1 at these residues [24]. It has been reported
that wild-type nm23-H1 and an S44A mutant suppressed motility,
whereas P96S suppressed motility to a lesser extent [25]. The
proline 96 to serinemutation is known to correspond to the killer of
prunemutation (Kpn; P96S) in theDrosophila homologue of nm23
(awd) [26]. The serine 120 to glycine (S120G) substitution has been
seen frequently in aggressive neuroblastomas [27]. Additionally,
complex interactions between nm23-H1 and KSR1 have been
reported. Through this interaction, the expression and the kinase
activity of nm23-H1 altered the scaffold properties of KSR1 and
attenuated ERK signaling required for metastatic invasion and
colonization [28]. It was recently reported that expression level of
nm23-H1 influences the binding properties, stability and function
of the KSR1 in breast carcinoma cells [29].
Invasion into surrounding tissues is a characteristic feature of
malignant tumors and an essential pattern of this process includes
the degradation of the extracellularmatrix (ECM) and the basement
membrane (BM). Many proteolytic enzymes produced by tumor
cells have been reported to degrade components of the ECM and
the BM [30–32]. It is known that the proteases involved in the
invasion are gelatinase, seprase, secreted metallo-type gelatinase,
and some others. Matrix metalloproteinases (MMPs) are zinc-
dependent enzymes with proteolytic activity that participate in the
degradation of ECM macromolecules. The induction of MMP-9
(gelatinaseB)was reported to bemediated byRas-Raf-MEK-ERK-
Elk-1 and PI3K-Akt-NF-κB/AP-1 pathways [33,34]. The expres-
sion of MMP-2 (gelatinase A) was also reported to be up-regulated
by the activation of the Ras-Rac-MKK3/6-p38 pathway [35].
In this study, we tested the interaction of rpS3 with nm23-H1
with respect to the reduction of invasion, the secretion of MMP-
9, and the activation of ERK signaling in order to reveal the
mechanism of the reduction of invasion by rpS3.
2. Materials and methods
2.1. Construction of deletion and point mutants
RpS3 deletion mutants were created by PCR amplification using primers
that confine the deleted region of rpS3. The nm23-H1 gene was a gift from
Professor Eunhee Kim at Chungnam National University, Daejeon, Republic of
Korea. RpS3 and nm23-H1 point mutants were constructed by two-step PCR
amplification. All mutants were confirmed by sequencing.
2.2. Plasmid
For the yeast two-hybrid system, rpS3 was inserted into pEG-202 (pEG-S3),
and nm23-H1 was inserted into pJG-4–5 (pJG-H1). For the pull-down assay, the
glutathione S-transferase (GST) gene (pGEX-5X-1) was fused to the N-terminal
of rpS3 (pGEX-S3) and 6xhistidine (pQE 30) was fused to the N-terminal of
nm23-H1 (pQE-H1). For transfection into HT1080, Flag-tagged (pcDNA Flag-S3, pcDNA Flag-H1), GFP-tagged (pEGFP-S3, pEGFP-H1), and GST-tagged
rpS3 (pEBG-S3) and nm23-H1 (pEBG-H1) were constructed.
2.3. Protein–protein interaction in the yeast two-hybrid system
pEG-S3 and pJG-H1 were transformed into an EGY048 yeast strain
containing pSH18–34, and the transformed cells were grown on a UHW-agar
plate for 3 days. Each colony was streaked onto a UHW-agar plate with X-
galactoside and grown for 2 days. The interaction between two proteins is
indicated by a color change from a white colony into a blue colony.
2.4. In vitro HIS pull-down assay
pGEX-S3 and pQE-H1 were overexpressed in BL-21, an E. coli strain. After
His-H1 was bound to Ni-NTA agarose (Quiagen), GST-S3 overexpressed cell
lysate was mixed and incubated for 12 h. Ni-NTA agarose was washed three
times with washing solution (50 mM Imidazole, 500 mM NaCl, and 20 mM
Tris–HCl (pH 7.9)) and was then eluted with elution solution (500 mM
Imidazole, 500 mMNaCl, and 20 mM Tris–HCl (pH 7.9)). Washing and elution
fractions were separated by 12% SDS-polyacrylamide gel and immunoblotted
with mouse anti-GST antibody (Santa Cruz Biotechnology).
2.5. Cell culture and transfection
The HT1080 human fibrosarcoma cell line was a gift from Dr. Shin-Wu
Jeong at LG Chemical Ltd. Research Park. HT1080 cells were maintained in
DMEM (Gibco BRL) supplemented with 10% fetal bovine serum (Gibco BRL).
The MCF7 human breast cancer cell line was maintained in RPMI 1640 (Gibco
BRL) supplemented with 10% fetal bovine serum. The genes were transfected
into cells using Superfect (Quiagen), as specified by the manufacturer.
Transfected HT1080 cells were treated with 800μg/ml of G418 (Gibco BRL)
in order to select cells in which the target genes were stably overexpressed.
2.6. Immunoprecipitation (IP) assay and in vivo GST pull-down assay
For the IP assay, trypsinized cells were washed with phosphate-buffered
saline (PBS), resuspended with IP buffer (50 mM Tris–HCl (pH 7.5), 150 mM
NaCl, 1% NP-40, 0.5% sodiumdeoxycholate, and protease inhibitors (PMSF,
leupeptin, aprotinin, pepstatin)), and lysed by sonication. The antibody (2 μg)
was added to each cell lysate (120 μg) and incubated in a rocking platform for
1 h at 4 °C. Protein A sephadex resin (bed volume; 20 μl) was used for the
precipitation and incubated for 16 h at 4 °C. After incubation, each sample was
washed three times with IP buffer. Each washed resin was mixed with 2× protein
loading buffer and boiled, after which the supernatant was separated by 10%
SDS-PAGE. Proteins were immunoblotted with the indicated antibodies.
For GST pull-down assay, glutathione sepharose 4B (Amersham Pharmacia)
was used. After binding to resin, procedures of washing and analysis are the
same as those of the IP assay.
2.7. Immunofluorescence assay
1×106 HT1080 cells were grown overnight in 35-mm plates with cover
slips. The cells were washed with PBS and fixed with 4% paraformaldehyde in
PBS for 20 min at room temperature. The fixed cells were washed with PBS and
permeabilized with 0.1% Triton X-100 in PBS for 10 min at room temperature.
Nonspecific binding was blocked twice with 2% BSA in PBS for 20 min at room
temperature. The permeabilized cells were then incubated with nm23-H1-
specific monoclonal (1:200 dilution) and rpS3-specific polyclonal (1:100
dilution) antibodies in PBS supplemented with 2% BSA for 1 h at room
temperature. The cells were then washed three times with 2% BSA in PBS for
10 min, followed by incubation with a fluorescein isothiocyanate-conjugated
goat anti-mouse antibody and a Texas Red-conjugated goat anti-rabbit
secondary antibody (Jackson Immunoresearch) at a dilution of 1:200 for 1 h
at room temperature. The stained cells were washed three times with 2% BSA in
PBS. Finally, coverslips were mounted using Vectashield mounting medium
(Biomeda) and analyzed by immunofluorescence microscopy using a 40× and
100× objective lens (Carl Zeiss).
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To determine invasiveness in vitro, the procedure of Albini et al. was used
[36]. The invasion was tested using 24-well transwell units with 8-μm pore
size polycarbonate filters (Corning Costar Corp.). Each filter in the transwell
unit was coated with Matrigel basement membrane (Collaborative Research)
in 50 ng Matrigel/0.1 ml DMEM/filter. Cells were plated at a density of 1×104
cells per well with 200 μl of DMEM.At this time, the same number of cells was
plated in one well of a 6-well plate to be used as a control for the number of
plated cells. The lower compartment of a transwell plate contained 600 μl ofFig. 1. Interaction of rpS3 with nm23-H1 in vitro. The interaction of wild-type and m
pull-down assay (B, C). (A) CΔ53, CΔ54, NΔ14, NΔ18, and L190A represent del
amino acids, 18 N-terminal amino acids, and substitution of the 190th leucine to alan
separated by SDS-PAGE. Upper panels were Western blotted with anti-GST antibod
indicated by arrows.DMEM containing 10% FBS. Cells were incubated in a humidified
atmosphere of 5% CO2 for 24 h at 37 °C. After incubation, cells on the
upper portion of the membrane were removed using cotton swabs. Cells were
fixed with 4% paraformaldehyde and stained with crystal violet. Invasion was
determined by counting the cells that migrated to the lower side of the filter
using optical microscopy at ×100. The number of cells was counted from
thirteen random fields. The number of cells harvested from 6-well plates was
also counted using a hemacytometer after trypsinization and staining with
trypan blue. The number of cells that had migrated was normalized by the
number of plated cells obtained from the 6-well plates. Invasion indices wereutant rpS3 with nm23-H1 was shown by yeast two-hybrid system (A), and HIS
etions of 53 C-terminal amino acids, 54 C-terminal amino acids, 14 N-terminal
ine, respectively. (B, C) After HIS pull-down washing and elution fractions were
y and lower panels were stained with Coomassie brilliant blue. The bands are
Fig. 2. Interaction of rpS3 with nm23-H1 in vivo. The interaction between endogenous (A) and exogenous (B, C) proteins was examined by IP and GST pull-down
assays. (A) Each antibody used for the Western blotting is shown below the result of each Western blot. The resulting bands and size markers are indicated by arrows.
* is nonspecific band (B) HT1080 cells were transfected with pEGFP-C1 and pcDNA Flag-S3 (lane: GFP, S3), pEGFP-H1 and pcDNA Flag-S3 (lane: H1, S3), and
pEGFP-H1 and pcDNA Flag-S3 L190A (lane: H1, S3L190A). Nm23-H1 was immunoprecipitated with mouse anti-GFP antibody; coimmunoprecipitation of rpS3
was detected by mouse anti-Flag antibody. (C) pEBG-S3 were co-transfected with pEGFP-C1 (GFP), pEGFP-H1 (wild-type), pEGFP-H1 S44A (S44A), pEGFP-H1
P96S (P96S), pEGFP-H1 H118F (H118F), and pEGFP-H1 S120G (S120G) into HT1080 cells. RpS3 proteins were purified with glutathione sepharose 4B and nm23-
H1 proteins were pulled-down and detected by mouse anti-GFP antibody.
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cells that migrated to the lower side of the filter, obtained from three separate
experiments.
2.9. MMP zymography
MMP-2 and MMP-9 activities in a conditioned medium of target cells
were analyzed by substrate-gel electrophoresis (zymography) using SDS-
PAGE (10%) containing 0.1% gelatin. The stable or transient transfected cells
were plated with same numbers of cells. Equal volumes of conditioned culture
medium of each sample were loaded onto the gel under non-reducing con-
ditions and separated by electrophoresis. Thereafter, gels were renaturated
with 2.5% Triton X-100 for 30 min at room temperature and developed for
18 h at 37 °C with development buffer (50 mM Tris–HCl, (pH 8.0), 20 mM
NaCl, 5 mM CaCl2, and 0.1% Triton X-100). Gels were stained with
Coomassie Brilliant Blue R-2500 (0.1%) and destained with 5% methanol
and 7% acetic acid. Gelatinolytic activity appears as a clear band on a blue
background.3. Results
3.1. In vitro interaction of rpS3 with nm23-H1
To find the functional partner of rpS3, yeast two hybrid
experiment was performed. RpS3 was used as bait in yeast two-
hybrid system and nm23 family proteins were screened by this
system, and nm23-H1 is known as a tumor cell metastasis sup-
pressor. RpS3 was known to have the altered chromatographic
column profile [2], overexpressed in colorectal cancer cells [4].
RpS3 and nm23-H1 may be involved in tumorigenesis and
metastasis. For this reason, the interaction of rpS3 with nm23-H1
was investigated in this study. To show the protein–protein
interaction, a yeast two-hybrid system was used. Two fusion
constructs, the full-length human rpS3 coupled with the LexA
DNA binding domain (pEG-S3) and the full-length human
nm23-H1 coupled with the B42 activator domain (pJG-H1),
were used in this system. Yeast strain EGY048 was transformedFig. 3. Nm23-H1 and rpS3 were colocalized in the cytosol and the membrane ruffle.
localization of nm23-H1 and rpS3 in HT1080 cells. Mouse nm23-H1-specific monoclon
(B) ×100 objective.with pEG-S3 and pJG-H1, and the transformed cells were
analyzed by X-gal assay. The yeast cells that were transformed
with wild-type rpS3 and wild-type nm23-H1 showed a blue
color, which indicates that two proteins interact directly each
other (Fig. 1A).
To determine the binding domain of rpS3, serially deleted
mutants of rpS3 were used for the yeast two-hybrid system. As
shown in Fig. 1A, the rpS3 deleted with 53 C-terminal amino
acids (CΔ53) interacted with wild-type nm23-H1, but the rpS3
mutant deleted with 54 C-terminal amino acids (CΔ54) did not
show any interaction. Among the proteins screened by the two-
hybrid system, several proteins interacted with both CΔ53 and
CΔ54 mutants (data not shown). The rpS3 mutant deleted with
14 N-terminal amino acids (NΔ14) interacted with nm23-H1,
but the rpS3 mutant deleted with 18 amino acids (NΔ18) did
not show interaction; these results were the same as those of a
yeast two-hybrid assay using other screened proteins (data not
shown). The result suggests that inhibition of the interaction of
rpS3 with nm23-H1 may result from a conformational change
of rpS3 induced by the deletion of 18 N-terminal amino acids.
To locate the critical amino acid residue, a point mutant,
L190A rpS3, was constructed. The L190A rpS3 mutant did not
bind to nm23-H1 in a yeast two-hybrid system (Fig. 1A).
These results suggested that the C-terminal region of rpS3 is
critical for interaction with nm23-H1; they also indicate that
the 190th leucine of rpS3 plays an important role in this
interaction.
To verify the interaction of rpS3 with nm23-H1, an in vitro
HIS pull-down assay was performed. As shown in Fig. 1B,
nm23-H1 did not bind to GST, but did bind to rpS3. It is also
shown in Fig. 1C that nm23-H1 interacted with rpS3, but did not
interact with L190A rpS3. These results suggest the interaction
of rpS3 with nm23-H1 and the critical role of the 190th leucine
of rpS3 for the interaction; these results are consistent with the
results of yeast two-hybrid assay.Immunofluorescence experiments were performed to determine the intracellular
al (green) and rabbit rpS3-specific polyclonal antibodies (red) were used. (A) ×40,
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To examine the interaction of rpS3 with nm23-H1 in vivo,
coimmunoprecipitation was performed. As shown in Fig. 2A,
endogenous rpS3 interacted with endogenous nm23-H1. To
confirm the in vivo interaction, HT1080 cells transiently trans-
fected with pcDNA Flag-S3 or pcDNA Flag-S3 L190A mutant
construct and pEGFP-H1 construct were used for the immuno-
precipitation assay. Fig. 2B shows that rpS3 was coimmuno-
precipitated with nm23-H1, but coimmunoprecipitation was not
seen between nm23-H1 and L190A rpS3. These results indicateFig. 4. Effects of rpS3 expression on invasiveness,MMP secretion, and ERK activation
control and stably transfected HT1080 cells was measured in a Boyden chamber. GFP-
lower surface of the polycarbonate membranes were counted after staining with cry
separate experiments. (*P-valueb0.03) (B) Inhibition ofMMP-9 secretion by rpS3. Th
by incubation with serum-free media for 24 h. Thereafter, the conditioned medium wa
lysates from cells of (B) were immunoblotted with mouse anti-phospho ERK and rabthat rpS3 interacts with nm23-H1 in vivo and that the 190th
leucine plays a key role in this in vivo interaction; these results
are consistent with the results of the in vitro experiments.
To identify the key amino acids of nm23-H1 for the inter-
action with rpS3, four nm23-H1 point mutants (S44A, P96S,
H118F and S120G) were constructed by two-step PCR. The
result (Fig. 2C) of the in vivo GST pull-down assay using
HT1080 cells transfected with the mutants shows that the 44th
serine and the 96th proline did not affect the interaction.
However, the mutations at the 118th phenylalanine and the 120th
serine were shown to inhibit the interaction of nm23-H1 within HT1080 cells. (A) Reduction of invasion in HT1080 cells by rpS3. Invasion of
SHwas co-transfected with GFP-S3 and GFP-H1 into HT1080 cells. Cells on the
stal violet. y axis, invasion index. Each bar represents the mean±S.D. of three
e conditionedmedia from control and stably transfectedHT1080 cells were taken
s analyzed by gelatin zymography. β-actin was used as internal control. (C) The
bit anti-ERK antibodies. Non-transfected cells are represented “−”.
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of nm23-H1 play important roles in the interaction with rpS3.
3.3. Localization of rpS3 and nm23-H1
To analyze the subcellular localization of rpS3 and nm23-H1,
an immunofluorescence assay was performed. The result of this
analysis shows that both rpS3 and nm23-H1 were primarily
found in the cytosol with some concentration in the nuclear
region (Fig. 3). RpS3 and nm23-H1 were also observed to be
highly concentrated at the edge or at the peripheral ruffles of
spreading cells (Fig. 3). These observations indicate that rpS3
and nm23-H1 appear to be colocalized at the cell periphery and
the cytoplasm in high concentrations.
3.4. Reduction of the invasion of HT1080 cells via the
inhibition of the MMP-9 secretion and the ERK activation
To investigate the effects of rpS3 on invasive properties, the
invasiveness was examined by Boyden chamber assay using
stable cell lines expressing GFP-fused proteins. The invasive-
ness of each cell line was represented by an invasion index,
which was calculated as described in Materials and methods.
The result (Fig. 4A) showed that the expression of rpS3 or nm23-
H1 decreased the invasive capacity of the cells. Co-expression of
rpS3 and nm23-H1 (GFP-SH) also showed a reduction of the
invasiveness, but did not show a synergic effect. However, it
should be noted that the invasive capacity of cells expressing
L190A rpS3 was not inhibited. These results strongly suggest
that rpS3 inhibits cell invasion in conjunction with nm23-H1.Fig. 5. Effects of rpS3 expression on MMP secretion and ERK activation in MCF7
expressing rpS3 and nm23-H1 were transiently treated with serum-free media contai
gelatin zymography. GFP-SH was co-transfected with GFP-S3 and GFP-H1 into MC
control. (B) The lysates from cells of (A) were immunoblotted with mouse anti-phoTo identify the mechanism by which rpS3 reduces invasion,
we determined the level of MMP secretion. Zymographic
analysis (Fig. 4B) revealed that the expression of rpS3 reduced
the amount of MMP-9 secreted by HT1080 cells and that the
expression of nm23-H1 decreased the secretion of MMP-2 and
MMP-9. However, expression of the L190A rpS3 mutant did not
show inhibition of MMP-9 secretion. The conditioned media was
obtained from the same cell number and internal control was
examined withβ-actin. These results suggest that the reduction in
invasion may result from the reduction of MMP-9 secretion
through the interaction of rpS3 with nm23-H1.
HT1080 cells are pseudo-diploid cells, each of which possess
a single mutant N-ras allele [37]. It was previously reported that
the Raf-MEK-ERK-Elk-1 pathway, as well as JNK, is consti-
tutively active in HT1080 cells [37]. In order to investigate
whether this pathway plays a role in the reduction of invasion
and MMP-9 secretion in this cell line, the level of active ERK
was measured by immunoblot assay using anti-phospho ERK
antibody (Santa Cruz Biotechnology). As shown in Fig. 4C, the
expression of rpS3 appears to suppress activated ERK. This
suppression was also shown in the nm23-H1-expressed and
rpS3/nm23-H1-co-expressed cells. In contrast, the L190A rpS3
mutant did not show a decrease in the level of active ERK. These
results, obtained from 3 independent experiments, suggest that
rpS3 inhibits the ERK pathway via the interaction of rpS3 with
nm23-H1 in HT1080 cells. Therefore, rpS3 appears to inhibit the
invasion of HT1080 cells through the inhibition of ERK acti-
vation followed by the reduction of MMP-9 secretion, while the
interaction of rpS3with nm23-H1 continues to play an important
role.cells activated by PMA. (A) The conditioned media from MCF7 cells and cells
ning 100 ng/ml of PMA for 24 h. The conditioned media were then analyzed by
F7 cells. Non-transfected cells are represented “−”. β-actin was used as internal
spho ERK and rabbit anti-ERK antibodies.
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PMA-treated MCF7 cells
It is known that the MCF7 breast cancer cell line is minimally
invasive and does not secrete MMP-9 orMMP-2 [38]. It was also
reported that the treatment of PMA induces the secretion of
MMP-9 and the activation of ERK signaling in MCF7 cells [39].
To investigate the effect of rpS3 on MMP secretion and ERK
activation in PMA-treated MCF7 cells, the cells were transiently
transfected with pEGFP-S3 and pEGFP-H1. After 24 h of incu-
bation, transfected cells were incubated for 24 h with serum-free
media containing 100 ng/ml PMA. The result of zymograph assay
(Fig. 5A) shows that PMA-treated MCF7 cells secreted MMP-9,
but did not secrete MMP-2. In this condition, the expression of
rpS3 or nm23-H1 resulted in the inhibition of MMP-9 secretion.
Through the immunoblot assay using anti-phospho ERK anti-
body, Fig. 5B shows that ERK activated by PMA in MCF7 cells
was inhibited by rpS3 and nm23-H1; the figure also shows that
the L190A rpS3 mutant did not affect this inhibition. From these
results, we conclude that the interaction of rpS3 with nm23-H1
may attenuate the phenomenon of invasion through the inhibition
of the ERK pathway, followed by the reduction of MMP-9
secretion.
4. Discussion
RpS3 functions in DNA repair, as well as in translation [2–4].
Nm23-H1 is known to be a suppressor of metastasis and has
many functional partners. RpS3 and nm23-H1 have been
suggested to be multifunctional proteins. In this study, we
showed the in vitro and in vivo interactions between the two
proteins. The colocalization of the two proteins at the cell
periphery and the cytoplasmwas also observed. We also showed
that the 190th leucine of rpS3, and the 118th histidine and 120th
serine of nm23-H1 play key roles in this interaction. We also
observed that the 190th leucine of rpS3 was not critical for the
interaction of rpS3 with other proteins (data not shown), which
suggests that this residue is a critical residue for the interaction
and may be related to the function of nm23-H1.
The phenotypes of nm23-H1 point mutants have been reported
previously [24,26,27].We showed that the critical binding sites of
nm23-H1 were the 118th and 120th amino acids. It was reported
that the mutations at these residues result in the loss of anti-
metastatic activity [40]. This activity was recently reported to be
implicated in the serine phosphorylation of the kinase suppressor
of ras (KSR). This suggests that anti-metastatic activity may arise
from the suppression of ras-initiated growth signals [28].
Therefore, it is suggested that the interaction of nm23-H1 with
rpS3 via these amino acids may be related to the inhibition of
invasion.
HT1080, a human fibrosarcoma cell line, is well known to be
a highly metastatic cell line and is known for its ability to move
through the ECM [41]. It has been established that nm23-H1
decrease metastatic potential in various cancers [42,43]. We
showed this relationship betweenmetastatic potential and nm23-
H1 expression in HT1080 cells, and that rpS3 expression inhibits
the invasion of HT1080 cells. The coexpression of rpS3 andnm23-H1 reduced invasion a bit more. Additionally, the L190A
rpS3 mutant did not show a decrease of invasion. These results
suggest that the inhibition of invasion by rpS3 and nm23-H1
results from this interaction.
ManyMMPs have been reported to be involved in the invasion
of cancer cells [44]. It is well known that HT1080 cells secrete
gelatinase, MMP-9, and MMP-2; it is also well known that a
decrease in this secretion inhibits invasion [45]. The expression of
MMPs has been reported to occur through the ERK signaling
pathway [33,34]. Since HT1080 cells have a single mutant N-ras
allele, the Ras-Raf-MEK-ERK pathway is constitutively activat-
ed, which results in a high invasiveness of HT1080 cells [46]. It
was previously reported that nm23-H1 interacts with KSR1 and
alters the scaffold properties of KSR1, which attenuates ERK
signaling [28].We showed that the interaction of rpS3with nm23-
H1 was able to decrease invasion, MMP-9 secretion, and ERK
activation, but interaction of the L190A rpS3 mutant with nm23-
H1 did not occur. It was also shown that the results obtained from
MCF7 cells activated by PMA are consistent with those obtained
from HT1080 cells.
In this paper, we are proposing that the interaction between
rpS3 and nm23-H1 is critical for the invasiveness of HT1080
cells. It is because our results showed that the stronger the
interaction between the two proteins, the smaller the activity of
MMP-9 thus inducing less invasiveness of HT1080 cells. The
several lines of evidence indicate this in our hands. First, the
L190A rpS3 mutant showed the decreased interaction between
the two proteins in vivo and in vitro. Second, the ectopic ex-
pression of wild type rpS3 protein, which is not harmful for the
cells, showed decreased phosphorylation of ERK. On the other
hand, the L190A rpS3 mutant did not change the status of the
phosphorylation of the protein. Third, the expression of the
L190A rpS3 mutant did not show the decreased activity of
MMP-9 protein thus resulting in the invasive potential. It is
likely that the interaction of rpS3 and nm23-H1 proteins exerts
influence on the interaction of nm23-H1 and KSR protein which
is a scaffold protein of Raf, MEK and Erk. Therefore, our results
and the previous reports indicate that the interaction of rpS3 with
nm23-H1 plays an important role in the inhibition of cell
invasion resulting from the decrease of ERK phosphorylation
followed by the reduction of MMP-9 secretion.
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